Evidence map›Paper›PMID 31574461›Full record

ArticleRedox biology2020

Insight into the mechanism of ferroptosis inhibition by ferrostatin-1.

Giovanni Miotto, Monica Rossetto, Maria Luisa Di Paolo, Laura Orian, Rina Venerando, Antonella Roveri, Ana-Marija Vučković, Valentina Bosello Travain, Mattia Zaccarin, Lucio Zennaro and 4 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 450 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
450citing papers in PubMed, 1 pooled it
31.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

450 citing papers in PubMed, 1 synthesis or guideline pooled it, 840 citations in OpenAlex.

  1. Pooled it
  2. Emerging microbes & infections · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

390 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Giovanni MiottoDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy; CRIBI Biotechnology Center, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Monica RossettoDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Maria Luisa Di PaoloDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Laura OrianDept. of Chemical Sciences, University of Padova, Via Marzolo, 1, I-35131, Padova, Italy.
Rina VenerandoDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Antonella RoveriDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Ana-Marija VučkovićDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Valentina Bosello TravainDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Mattia ZaccarinDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Lucio ZennaroDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Matilde MaiorinoDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Stefano ToppoDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy; CRIBI Biotechnology Center, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy.
Fulvio UrsiniDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy. Electronic address: fulvio.ursini@unipd.it.
Giorgio CozzaDept. of Molecular Medicine, University of Padova, V.le G. Colombo, 3, I-35121, Padova, Italy. Electronic address: giorgio.cozza@unipd.it.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is a form of cell death primed by iron and lipid hydroperoxides and prevented by GPx4. Ferrostatin-1 (fer-1) inhibits ferroptosis much more efficiently than phenolic antioxidants. Previous studies on the antioxidant efficiency of fer-1 adopted kinetic tests where a diazo compound generates the hydroperoxyl radical scavenged by the antioxidant. However, this reaction, accounting for a chain breaking effect, is only minimally useful for the description of the inhibition of ferrous iron and lipid hydroperoxide dependent peroxidation. Scavenging lipid hydroperoxyl radicals, indeed, generates lipid hydroperoxides from which ferrous iron initiates a new peroxidative chain reaction. We show that when fer-1 inhibits peroxidation, initiated by iron and traces of lipid hydroperoxides in liposomes, the pattern of oxidized species produced from traces of pre-existing hydroperoxides is practically identical to that observed following exhaustive peroxidation in the absence of the antioxidant. This supported the notion that the anti-ferroptotic activity of fer-1 is actually due to the scavenging of initiating alkoxyl radicals produced, together with other rearrangement products, by ferrous iron from lipid hydroperoxides. Notably, fer-1 is not consumed while inhibiting iron dependent lipid peroxidation. The emerging concept is that it is ferrous iron itself that reduces fer-1 radical. This was supported by electroanalytical evidence that fer-1 forms a complex with iron and further confirmed in cells by fluorescence of calcein, indicating a decrease of labile iron in the presence of fer-1. The notion of such as pseudo-catalytic cycle of the ferrostatin-iron complex was also investigated by means of quantum mechanics calculations, which confirmed the reduction of an alkoxyl radical model by fer-1 and the reduction of fer-1 radical by ferrous iron. In summary, GPx4 and fer-1 in the presence of ferrous iron, produces, by distinct mechanism, the most relevant anti-ferroptotic effect, i.e the disappearance of initiating lipid hydroperoxides.

Indexed as

AntioxidantsCell DeathChromatography, LiquidCyclohexylaminesDensity Functional TheoryDose-Response Relationship, DrugFerroptosisHydrogenLipidomicsLipid PeroxidationLipid PeroxidesLipidsModels, MolecularMolecular StructureOxidation-ReductionPhenylenediaminesAntioxidantsCyclohexylaminesferrostatin-1HydrogenLipid PeroxidesLipidsPhenylenediaminesAlkoxyl radicalAntioxidantFerroptosisFerrostatin-1GPx4Lipid peroxidation

Identifiers

PMID31574461
PMCPMC6812032
OpenAlexW2804834775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.